Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
How Has the Macular Degeneration Treatment Market Size Shifted in Recent Years?
In recent times, the market size for the treatment of macular degeneration has experienced swift expansion. The market value is set to increase from $11.05 billion in 2024 to $12.38 billion in 2025, marking a compound annual growth rate (CAGR) of 12.0%.
Factors contributing to the growth during this historical period include an aging population, modifications in lifestyle, scarceness of treatment alternatives, increasing consciousness, and development in healthcare infrastructure.
The market for macular degeneration treatment is projected to experience swift expansion in the approaching years. The market value is anticipated to reach $18.87 billion by 2029, with a compound annual growth rate (CAGR) of 11.1%.
The predicted growth during this period can be linked to progress in research, substantial increases in healthcare spending, rising incidences of the condition, tailored medicine strategies, and worldwide initiatives for vision health. Key trends within this timeframe include emphasis on neuroprotection and regeneration therapies, the enlargement of telemedicine and distant monitoring, targeted medical approaches, exploring stem cell therapies, and patient-centric programs for awareness and education.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What’s Behind the Consistent Growth of the Macular Degeneration Treatment Industry?
The escalating pressure of retinal disorders is anticipated to accelerate the expansion of the macular degeneration treatment market. These disorders impact the essential tissue, hindering individuals’ ability to interpret visual information, leading to contorted vision or complete lack of it.
For example, the American Academy of Ophthalmology predicts that by 2050 approximately 7.32 million people in the United States will suffer from primary open-angle glaucoma, a term encapsulating a variety of eye disorders. This condition will predominantly affect people aged 70 to 79 years (32%), women (50%), and Hispanics (50%), with the largest group being Hispanic males.
Consequently, the escalating impact of retinal disorders is fueling the expansion of the macular degeneration treatment market.
Top Revenue-Generating Segments in the Macular Degeneration Treatment Market
The macular degeneration treatmentmarket covered in this report is segmented –
1) By Stage of Disease: Early-Stage AMD; Intermediate AMD; Late-Stage AMD
2) By End User: Ambulatory Surgical Centers; Ophthalmic Clinics; Hospitals
3) By Route of Administration: Oral; Injectable; Other Route of Administration
4) By Types: Wet Macular Degeneration, Dry Macular Degeneration
Subsegments:
1) By Early-Stage AMD: Nutritional Supplements; Lifestyle Modification Treatments
2) By Intermediate AMD: Anti-VEGF Injections; Photodynamic Therapy
3) By Late-Stage AMD: Surgical Treatments; Advanced Anti-VEGF Therapies; Gene Therapy Options
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
What Technological Trends Are Set to Revolutionize the Macular Degeneration Treatment Market?
Top-tier businesses in the AMD treatment market are concentrating on developing biosimilars for handling age-related macular degeneration (AMD) to enhance the accessibility to effective treatments.
Biosimilars are biological medications that are extremely equivalent to an already approved reference drug, providing identical safety, purity, and potency levels.
For example, in May 2024, Biocon Biologics Ltd from India partnered with Samsung Bioepis Co. Ltd from South Korea to receive FDA approvals for Yesafili and Opuviz, two novel biosimilars.
These biosimilars effectively inhibit the VEGF, which is crucial for unusual blood vessel growth in the eye, thereby preventing conditions like AMD and diabetic retinopathy that could lead to vision loss. The FDA sanctioned these drugs after thorough comparative studies with Eylea demonstrated negligible differences in efficacy and safety.
These included strict evaluations of the biosimilars’ pharmacokinetics and immunogenic features.
How Are Different Regions Contributing to the Macular Degeneration Treatment Market’s Growth?
North America was the largest region in the macular degeneration treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period.
The regions covered in the macular degeneration treatment Market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Which Firms Are Setting the Benchmark in the Global Macular Degeneration Treatment Market?
Major companies operating in the macular degeneration treatment market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Allergan Inc., Bayer AG, Novartis AG, GlaxoSmithKline plc, Panoptica, Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Santen Pharmaceuticals, Aerie Pharmaceuticals Inc., BioXcel Therapeutics Inc., Regenxbio Inc., Spark Therapeutics Inc., Alimera Sciences Inc., Applied Genetic Technologies Corp (AGTC), Cell Medica Ltd., Ophthotech Corporation, Adverum Biotechnologies Inc., Neurotech Pharmaceuticals Inc., 4D Molecular Therapeutics Inc., GenSight Biologics Inc.
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…px?id=5799
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
